These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23636469)

  • 1. Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.
    Uribarri J; Cai W; Pyzik R; Goodman S; Chen X; Zhu L; Ramdas M; Striker GE; Vlassara H
    Amino Acids; 2014 Feb; 46(2):301-9. PubMed ID: 23636469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.
    Uribarri J; Cai W; Ramdas M; Goodman S; Pyzik R; Chen X; Zhu L; Striker GE; Vlassara H
    Diabetes Care; 2011 Jul; 34(7):1610-6. PubMed ID: 21709297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.
    Vlassara H; Cai W; Goodman S; Pyzik R; Yong A; Chen X; Zhu L; Neade T; Beeri M; Silverman JM; Ferrucci L; Tansman L; Striker GE; Uribarri J
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4483-91. PubMed ID: 19820033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.
    Cai W; Ramdas M; Zhu L; Chen X; Striker GE; Vlassara H
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15888-93. PubMed ID: 22908267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
    Cai W; Uribarri J; Zhu L; Chen X; Swamy S; Zhao Z; Grosjean F; Simonaro C; Kuchel GA; Schnaider-Beeri M; Woodward M; Striker GE; Vlassara H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4940-5. PubMed ID: 24567379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.
    Lopez-Moreno J; Quintana-Navarro GM; Camargo A; Jimenez-Lucena R; Delgado-Lista J; Marin C; Tinahones FJ; Striker GE; Roche HM; Perez-Martinez P; Lopez-Miranda J; Yubero-Serrano EM
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28233454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.
    Di Pino A; Currenti W; Urbano F; Scicali R; Piro S; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):978-984. PubMed ID: 28958695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?
    Uribarri J; Cai W; Woodward M; Tripp E; Goldberg L; Pyzik R; Yee K; Tansman L; Chen X; Mani V; Fayad ZA; Vlassara H
    J Clin Endocrinol Metab; 2015 May; 100(5):1957-66. PubMed ID: 25695886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.
    Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE
    Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.
    Cai W; He JC; Zhu L; Chen X; Wallenstein S; Striker GE; Vlassara H
    Am J Pathol; 2007 Jun; 170(6):1893-902. PubMed ID: 17525257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.
    Torreggiani M; Liu H; Wu J; Zheng F; Cai W; Striker G; Vlassara H
    Am J Pathol; 2009 Oct; 175(4):1722-32. PubMed ID: 19779136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
    Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
    J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation.
    Cai W; He JC; Zhu L; Chen X; Striker GE; Vlassara H
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C145-52. PubMed ID: 18032526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
    PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
    Semba RD; Gebauer SK; Baer DJ; Sun K; Turner R; Silber HA; Talegawkar S; Ferrucci L; Novotny JA
    J Nutr; 2014 Jul; 144(7):1037-42. PubMed ID: 24744309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
    Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH
    Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products reveals a mechanism regulating thyroid hormone secretion through the SIRT1/Nrf2 pathway.
    Chen XJ; Gong XH; Jie JP; Yu WH; Chen X; Du X; Zhou Q; Wu WJ
    J Cell Biochem; 2019 Mar; 120(3):4582-4598. PubMed ID: 30320918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum advanced glycation end products and dietary intake of advanced glycation end products estimated from home cooking and food frequency questionnaires.
    Vasilj M; Goni L; Gayoso L; Razquin C; Sesma MT; Etxeberria U; Ruiz-Canela M
    Nutr Metab Cardiovasc Dis; 2023 Sep; 33(9):1768-1777. PubMed ID: 37414659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation.
    Cho RL; Lin WN; Wang CY; Yang CC; Hsiao LD; Lin CC; Yang CM
    Biochem Pharmacol; 2018 Feb; 148():222-237. PubMed ID: 29309760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.